June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Establishment of an ex vivo retinitis pigmentosa model by efficient delivery of PRPF31 siRNA to human organotypic retinal culture
Author Affiliations & Notes
  • Narsis Daftarian
    Ophthalmology, Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)
    Ophthalmology, Ophthalmic Research Center, Shahid Beheshti University o Medical Sciences, Tehran, Iran (the Islamic Republic of)
  • Leila Azizzadeh Pormehr
    Biochemistry and Biophysics, Dept. of Biochemistry, Institute ofBiochemistry and Biophysics, University of Tehran, Tehran, Tehran, Iran (the Islamic Republic of)
    Ophthalmology, Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)
  • Shahin Ahmadian
    Biochemistry and Biophysics, Dept. of Biochemistry, Institute ofBiochemistry and Biophysics, University of Tehran, Tehran, Tehran, Iran (the Islamic Republic of)
  • Mozhgan Rezaei Kanavi
    Ophthalmology, Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)
    Ophthalmology, Ophthalmic Research Center, Shahid Beheshti University o Medical Sciences, Tehran, Iran (the Islamic Republic of)
  • Hamid Ahmadieh
    Ophthalmology, Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)
    Ophthalmology, Ophthalmic Research Center, Shahid Beheshti University o Medical Sciences, Tehran, Iran (the Islamic Republic of)
  • Footnotes
    Commercial Relationships   Narsis Daftarian, None; Leila Azizzadeh Pormehr, None; Shahin Ahmadian, None; Mozhgan Rezaei Kanavi, None; Hamid Ahmadieh, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4526. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Narsis Daftarian, Leila Azizzadeh Pormehr, Shahin Ahmadian, Mozhgan Rezaei Kanavi, Hamid Ahmadieh; Establishment of an ex vivo retinitis pigmentosa model by efficient delivery of PRPF31 siRNA to human organotypic retinal culture. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4526.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The splicing factor PRPF31 is the most commonly mutated general splicing factor in the autosomal dominant retinitis pigmentosa. There is a high demand for safe and efficient delivery of siRNA into Human Organotypic Retinal Culture (HORC). We used a rapid, convenient and safe transfection method with an efficient PRPF31 knockdown in HORC in order to study the PRPF31 silencing effect on retinal gene expressions in this ex vivo model.

Methods : Donor human eyes were obtained within the 24 hours post mortem from Iranian eye bank in compliance with the Declaration of Helsinki. The retinas were isolated and cultured in DMEM serum free medium. HORC transfection using PRPF31 siRNA and scramble siRNA as negative control were done with modified calcium phosphate method. PRPF31 down regulation was assessed by quantitative real time PCR (qPCR) within 63 hours. The tissue viability of HORC was measured using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The PRPF31 gene down regulation effects on retinal gene expression such as RP1, GNAT and ROM were analyzed by qPCR.

Results : After 63 hours of calcium phosphate transfection method in HORC, the qPCR results showed that the levels of PRPF31 mRNA was reduced significantly in the PRPF31 siRNA treated samples in comparison to controls (over 90%). The PRPF31 mRNA silencing with calcium phosphate had no effect on cell viability in the time period of experiment. PRPF31 reduced expression in the siRNA treated samples led to reduction of retinal specific gene expression such as RP1 (over 100 times), GNAT (10 times) and ROM (10 times) compared to controls, based on qPCR results.

Conclusions : We represent an efficient and safe delivery method of PRPF31 siRNA to HORC that could be a useful tool for ex vivo modeling of RP disease. Other than significant effect of PRPF31 down regulation on reduction of RP1, GNAT and ROM gene expression detected by qPCR in this study, further examinations for understanding of PRPF31 down regulation effects in HORC are in progress.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×